1198420-06-2

Basic information

• Product Name: methyl 5-chloro-2-{[(3-chlorophenyl)methyl]oxy}benzoate
• Synonyms: methyl 5-chloro-2-{[(3-chlorophenyl)methyl]oxy}benzoate
• CAS NO: 1198420-06-2
• Molecular Weight: 311.164
• Mol File: 1198420-06-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl 5-chloro-2-{[(3-chlorophenyl)methyl]oxy}benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 5-chloro-2-{[(3-chlorophenyl)methyl]oxy}benzoate(1198420-06-2)
• EPA Substance Registry System: methyl 5-chloro-2-{[(3-chlorophenyl)methyl]oxy}benzoate(1198420-06-2)

Safety Data

• Hazardous Substances Data: 1198420-06-2(Hazardous Substances Data)

Upstream product

• 4068-78-4 methyl 5-chloro-2-hydroxybenzoate 
• 766-80-3 1-bromomethyl-3-chlorobenzene 

Downstream Products

• 1198420-07-3 ethyl (3-chloro-4-{[(5-chloro-2-{[(3-chlorophenyl)methyl]oxy}phenyl)carbonyl]amino}phenyl)acetate 
• 1198420-24-4 ethyl (3-chloro-4-{[(5-chloro-2-{[(2-chlorophenyl)methyl]oxy}phenyl)carbonyl]amino}phenyl)acetate 
• 1198420-15-3 ethyl (4-{[(5-chloro-2-{[(3-chlorophenyl)methyl]oxy}phenyl)carbonyl]amino}-2-fluorophenyl)acetate 
• 1198420-08-4 GSK₂₅₃A 
• 1198420-25-5 (3-chloro-4-{[(5-chloro-2-{[(2-chlorophenyl)methyl]oxy}phenyl)carbonyl]amino}phenyl)acetic acid 
• 1198420-16-4 (4-{[(5-chloro-2-{[(3-chlorophenyl)methyl]oxy}phenyl)carbonyl]amino}-2-fluorophenyl)acetic acid 
• 62176-34-5 5-chloro-2-{[(3-chlorophenyl)methyl]oxy}benzoic acid 

Relevant articles and documents

NOVEL EP4 RECEPTOR AGONIST COMPOUNDS

A compound selected from the group consisting of: (3-chloro-4-{[(5-chloro-2-{[(2- chlorophenyl)methyl]oxy}phenyl)carbonyl]amino}phenyl)acetic acid; {4-[({5-chloro-2-[(phenylmethyl)oxy]phenyl}carbonyl)amino]phenyl}acetic acid; {3-chloro-4-[({5-chloro-2-[(phenylmethyl)oxy]phenyl}carbonyl)amino]phenyl}acetic acid; (3-chloro-4-{[(5-chloro-2-{[(3- chlorophenyl)methyl]oxy}phenyl)carbonyl]amino}phenyl)acetic acid; {4-[({2-[(phenylmethyl)oxy]phenyl}carbonyl)amino]phenyl}acetic acid; (4-{[(5-chloro-2-{[(3-chlorophenyl)methyl]oxy}phenyl)carbonyl]amino}-2- fluorophenyl)acetic acid; {3-chloro-4-[({2-[(phenylmethyl)oxy]phenyl}carbonyl)amino]phenyl}acetic acid; (3-chloro-4-{[(2-{[(3-chlorophenyl)methyl]oxy}phenyl)carbonyl]amino}phenyl)acetic acid; {4-[({2-chloro-6-[(phenylmethyl)oxy]phenyl}carbonyl)amino]phenyl}acetic acid; (4-{[(2-chloro-6-{[(3-chlorophenyl)methyl]oxy}phenyl)carbonyl]amino}phenyl)acetic acid; {4-[({5-chloro-2-[(phenylmethyl)amino]phenyl}carbonyl)amino]phenyl}acetic acid; (4-{[(5-chloro-2-{[(3-chlorophenyl)methyl]amino}phenyl)carbonyl]amino}phenyl)acetic acid; and (4-{[(5-chloro-2-{[(2-chlorophenyl)methyl]amino}phenyl)carbonyl]amino}phenyl)acetic acid, or pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.